Table 1—

Baseline characteristics of 30 patients treated with rosiglitazone and 34 patients treated with placebo

RosiglitazonePlacebo
Age (years)58.9 ± 9.457.8 ± 8.9
Sex (M/F)13/1713/21
Body weight (kg)64.9 ± 11.865.3 ± 11.2
BMI (kg/m2)25.76 ± 2.8725.84 ± 3.50
Systolic blood pressure (mmHg)127.8 ± 13.8134.8 ± 18.8
Diastolic blood pressure (mmHg)79.5 ± 10.580.2 ± 10.0
Fasting plasma glucose (mmol/l)10.7 ± 2.711.0 ± 2.9
Fasting plasma insulin (pmol/l)69.6 ± 33.375.7 ± 45.2
Insulin resistance (by HOMA)1.08 ± 0.611.16 ± 0.63
HbA1c (%)9.5 ± 1.19.7 ± 1.4
  • Data are means ± SD.